CLINICAL_TRIALS
research
· 2025-05-22
Clinical Trial Update: B-Complex: A Nutraceutical SANS Countermeasure [Phase 1]
Summary
Phase 1 trial assessing a B-Complex nutraceutical as a countermeasure for spaceflight-associated neuro-ocular syndrome (SANS). The study targets optic disc edem…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Aeronautics and Space Administration (NASA) | Conditions: Optic Disc Edema, Endothelial Dysfunction | Phase 1 | Status: RECRUITING